Transcript
Sam Baker (0:00)
Cohn, author of our Breakdown newsletter, who is going to talk to us about a just concluded Senate help committee hearing involving Dr. Susan Menarez, formerly the head of the CDC. This comes a couple of weeks after she was dismissed fired by President Trump ultimately, which came a little bit after three top CDC officials resigned in protest over RFK Jr. And what he's doing to the agency. There's a lot to unpack here, like a metric ton to unpack here. We'll start with the actual most important stuff and then get to the political stuff. There were a few moments where Dr. Manaras talked about things that are about to happen with respect to vaccines in this country. We have a very important meeting coming up in the next day and then the day after that with the CDC's Advisory Committee on vaccines. And they're going to be looking at things like the Hepatitis B vaccine recommendations, childhood vaccine schedule and so on and so forth. There was real news made in, in this hearing. What's to come. Jonathan, why don't you unpack that for us first?
Jonathan Cohn (1:02)
Yeah, there was a lot of discussion about the Hep B vaccine. Hep B, real quickly, Hepatitis B, liver disease. We have a vaccine that we currently recommend is given to newborns right after birth, like in the first day now. And the reason is children can get it very easily at birth in their early months, and if they do, there's a 90% chance that they develop a chronic version that can develop into cirrhosis, liver cancer. Really hard, horrible stuff. Actually, what I wrote about today at the Breakdown in my newsletter is all about this, right. We knew there's been reporting that Kennedy was interested and his people were interested in changing the recommendation and pushing back that first dose. There's been some reporting that affect. There's an item on the agenda for this week. There's this meeting coming up this week to reconsider what is on the childhood vaccine schedule. But we have, you know, the agenda doesn't say what they're considering. And it was just sort of these vague reports. I thought it was newsworthy. And, you know, and I haven't seen every single thing written. So maybe this has been out there. But it sounded newsworthy to me that Deborah Howery, who is one of the career scientists who resigned when Menares was pushed out, she said she heard directly from Kennedy and his office that they wanted to push back the recommendation and push it all the way back to four years.
Sam Baker (2:17)
So you wouldn't have seen. Yeah, yeah.
Jonathan Cohn (2:19)
So you'd have, you wouldn't get your first dose of the Hep B vaccine until you're four years old. Which just to think about this for a second, those four years, very easy to get exposed to hepatitis B if not at birth, from a caregiver, from an adult who doesn't even know they have. I mean, it's one of those diseases, super easy to transmit. And again, horrible stuff happens. People die from complications of Hep B. And again, just to take a story from my newsletter today, I spoke to a doctor who's up in Alaska and used to treat these patients. He told this just heart wrenching stories about watching children die from liver cancer.
